About Us

Fairfax Diagnostics is a division of Genetics & IVF Institute (GIVF) and is part of the Fairfax Cryobank and Fairfax EggBank family. We began performing Preimplantation Genetic Testing (PGT) in 1993 and we have performed more than 5,000PGT cycles, helping families across the country and around the world have healthy babies.

We use Illumina’s VeriSeq protocol and BlueFuse Multi data analysis software, the most advanced Next Generations Sequencing (NGS) technology available to perform PGT. Our team has designed hundreds of custom assays for the common genetic disorders and we have specialized in strategies for highly complex genetic lesions, compound heterozygotes, and multi-gene PGT cases.

All results are reviewed by a team of molecular and clinical PhD/MD experts. Our Medical and Laboratory Directors each have over 20 years of experience at Fairfax Diagnostics and our lab maintains a zero misdiagnosis rate in all PGT program.

Fairfax Diagnostics can design PGT-M assays for almost all genetic disorders that have been characterized by a genetic report. Some of our most recent PGT-M cases include:

• C9orf72; FTD-ALS
• Anti-C
• Mitochondrial disorder; Leigh’s Disease
• Joubert Disease
• Compound heterozygous CFTR mutations
• Trinucleotide expansions;
  • HD, Fragile X, Myotonic Dystrophy
• Hereditary Non-Pressure Palsy, 1.5 Megabase deletion
• Prion gene mutations; PRPP
• Compound Sickle Cell Disease (S/C)